OWENS DAVID (Chief Medical Officer) purchased 1.1% of their position (1.62K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $1.1K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/21/2024ACC: 0001829126-24-004353
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1.62K
Net shares
Net buyer
$1.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.62K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1.62K
Price / share
$0.71
Trade value
$1.15K
% of position
1.1%
6/18/2024
144.17K→145.79K
Total
Net shares
+1.62K
Net value
$1.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/18/2024 | P · Purchase | +1.62K | $0.71 | $1.15K | 1.1% | 144.17K | 145.79K |
| Total | +1.62K | $1.15K | ||||||
Derivative Transactions0
No derivative transactions reported